Bradley McGregor

Harvard University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (9)

Lucia Kwak

Johns Hopkins University

UNITED STATES

View details

Frede Donskov

DENMARK

View details

Srinivas Viswanathan

Dana-Farber Cancer Institute

UNITED STATES

View details

Shankar Siva

University of Melbourne

AUSTRALIA

View details

Wenxin Xu

Assistant Professor of Medicine

Dana-Farber Cancer Institute

UNITED STATES

View details

Christina Bligaard Pedersen

Technical University of Denmark

DENMARK

View details

J. Bryan Iorgulescu

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Bernadett Szabados

Barts Cancer Institute

UNITED KINGDOM

View details

Lars Rønn Olsen

Technical University of Denmark

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bradley McGregor

Research Interests

Explore related searches

Contact this professor

Articles (10)

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

CDK4/6 Inhibition With Abemaciclib in Patients With Previously Treated Advanced Renal Cell Carcinoma

COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts

Characterization of FOLH1 Expression in Renal Cell Carcinoma

The role of ablative therapy for primary and oligometastatic renal cell carcinoma

The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma

Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial

Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma

CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).

The Continuing Question of Adjuvant Therapy in Clear Cell Renal Cell Carcinoma

Collaborators (9)

Lucia Kwak

Frede Donskov

Srinivas Viswanathan

Shankar Siva

Wenxin Xu

Christina Bligaard Pedersen

J. Bryan Iorgulescu

Bernadett Szabados

Lars Rønn Olsen

Make your next move.